Human mesenchymal stem cells maintain transgene expression during expansion and differentiation

Area of Science:

• Stem cell biology
• Gene therapy
• Regenerative medicine

Background:

• Human mesenchymal stem cells (hMSCs) support hematopoiesis and tissue regeneration.
• Transducing hMSCs with therapeutic genes is a potential strategy for in vivo gene delivery.
• Maintaining transgene expression after stem cell differentiation is crucial for clinical applications.

Purpose of the Study:

• To demonstrate that transduced hMSCs maintain transgene expression after stem cell differentiation in vitro and in vivo.
• To assess the long-term expression of human interleukin 3 (hIL-3) and green fluorescent protein (GFP) in transduced hMSCs.
• To evaluate the potential of hMSCs as cellular vehicles for systemic gene delivery.

Main Methods:

• Retroviral vector transfer was used to introduce genes into cultured hMSCs.
• In vitro differentiation into osteogenic, adipogenic, and chondrogenic lineages was performed.
• In vivo studies utilized NOD/SCID mice, with hMSCs delivered via various routes.
• Systemic hIL-3 expression was monitored in peripheral blood samples.

Main Results:

• High transduction efficiencies (80-90%) were achieved in hMSCs.
• Long-term in vitro expression of hIL-3 and GFP was maintained over 17 passages (> 6 months).
• Transduced hMSCs retained transgene expression after differentiation into multiple lineages.
• In vivo, systemic hIL-3 expression was sustained for 3 months in mice.

Conclusions:

• Transduced hMSCs can maintain transgene expression after differentiation, both in vitro and in vivo.
• hMSCs demonstrate potential as cellular vehicles for delivering therapeutic genes systemically.
• These findings support the clinical utility of hMSCs for gene therapy applications.